Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Tyler Lahusen,Chu‐Xia Deng

DOI: https://doi.org/10.1158/1535-7163.22501758

2023-01-01

Abstract:Supplementary Figure 2. Control and SIRT1 knockdown MDA-MB-231 cells treated with a dose range of resveratrol for 24 hours

What problem does this paper attempt to address?

Data from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Tyler J. Lahusen,Chu-Xia Deng

DOI: https://doi.org/10.1158/1535-7163.c.6536892.v1

2023-01-01

Abstract:AbstractSRT1720 is an activator of SIRT1, a NAD+-dependent protein and histone deacetylase that plays an important role in numerous biologic processes. Several studies have illustrated that SRT1720 treatment could improve metabolic conditions in mouse models and in a study in cancer SRT1720 caused increased apoptosis of myeloma cells. However, the effect of SRT1720 on cancer may be complex, as some recent studies have demonstrated that SRT1720 may not directly activate SIRT1 and another study showed that SRT1720 treatment could promote lung metastasis. To further investigate the role of SRT1720 in breast cancer, we treated SIRT1 knockdown and control breast cancer cell lines with SRT1720 both in vitro and in vivo. We showed that SRT1720 more effectively decreased the viability of basal-type MDA-MB-231 and BT20 cells as compared with luminal-type MCF-7 breast cancer cells or nontumorigenic MCF-10A cells. We demonstrated that SRT1720 induced lysosomal membrane permeabilization and necrosis, which could be blocked by lysosomal inhibitors. In contrast, SRT1720-induced cell death occurred in vitro irrespective of SIRT1 status, whereas in nude mice, SRT1720 exhibited a more profound effect in inhibiting the growth of allograft tumors of SIRT1 proficient cells as compared with tumors of SIRT1-deficient cells. Thus, SRT1720 causes lysosomal-dependent necrosis and may be used as a therapeutic agent for breast cancer treatment. Mol Cancer Ther; 14(1); 183–92. ©2014 AACR.
Supplementary Figure 5 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Tyler J. Lahusen,Chu-Xia Deng

DOI: https://doi.org/10.1158/1535-7163.22501749.v1

2023-01-01

Abstract:Supplementary Figure 5. Cell viability of WT and ATF3-/- MEFs treated with SRT1720
Supplemental Figures 1-5 from SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents

Warren Fiskus,Veena Coothankandaswamy,Jianguang Chen,Hongwei Ma,Kyungsoo Ha,Dyana T. Saenz,Stephanie S. Krieger,Christopher P. Mill,Baohua Sun,Peng Huang,Jeffrey S. Mumm,Ari M. Melnick,Kapil N. Bhalla

DOI: https://doi.org/10.1158/0008-5472.22413911

2023-01-01

Abstract:Supplemental Figure 1. Relative activity of overexpressed SIRT2 in breast cancer cells Supplemental Figure 2. Expression of other sirtuin proteins and HDAC6 in SIRT2 O/E and knockdown cells Supplemental Figure 3. SIRT2 overexpression increases Prdx1 chaperone activity in HEK293 cells treated with H2O2. Supplemental Figure 4. Effects of SIRT2 overexpression on FOXO3A localization Supplemental Figure 5. Schematic of the zebrafish SIRT2 gene and splice-blocking exon 6 morpholino.
Resveratrol Induces Gastric Cancer Cell Apoptosis Via Reactive Oxygen Species, but Independent of Sirtuin1.

Zhengguang Wang,Weiping Li,Xiangling Meng,Benli Jia

DOI: https://doi.org/10.1111/j.1440-1681.2011.05660.x

2011-01-01

Clinical and Experimental Pharmacology and Physiology

Abstract:Summary The currently available chemotherapeutic regimens against gastric cancer are not very effective, leading to high recurrence and poor survival. Resveratrol is a naturally occurring polyphenol with potent apoptosis‐inducing activity. However, the mechanism underlying its actions remains unknown. In the present study, human gastric adenocarcinoma SGC7901 cells were treated with resveratrol (0, 25, 50, 100 and 200 μmol/L) for 48 h, and cellular apoptosis DNA damage were determined. In certain experiments, cells were incubated with superoxide dismutase (100 U/mL), catalase (300 U/mL) or sirtinol (10 μmol/L) to determine the role of reactive oxygen species (ROS) and sirtuin1 in resveratrol‐induced cellular apoptosis. Treatment with resveratrol (50–200 μmol/L) for 48 h significantly induced apoptosis and DNA damage in human gastric cancer SGC7901 cells. This was due to the increased generation of ROS following resveratrol treatment because incubation of cells with superoxide dismutase (100 U/mL) or catalase (300 U/mL) attenuated resveratrol‐induced cellular apoptosis. Interestingly, treatment with resveratrol (25–200 μmol/L) did not affect the level and activity of sirtuin1, whereas the sirtuin1 inhibitor sirtinol (10 μmol/L) significantly reduced sirtuin1 activity. Furthermore, treatment with sirtinol (10 μmol/L) did not have any effect on apoptosis induced by resveratrol. These data provide evidence that resveratrol induces apoptosis via ROS, but independent of sirtuin1, in the human gastric cancer cell line SGC7901.
Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong-Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming‐Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497787

2023-01-01

Abstract:PDF file - 63K, Figure S1: Expression of RON and MET by breast cancer MCF-7, T-47D and ZR-75-1 cells.
Supplementary Figure 2 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Sharad Sharma,Junying Zeng,Chun-Mei Zhuang,Yong‐Qing Zhou,Hang‐Ping Yao,Xing Hu,Ruiwen Zhang,Ming-Hai Wang

DOI: https://doi.org/10.1158/1535-7163.22497784.v1

2023-01-01

Abstract:PDF file - 68K, Figure S2: Effect of BMS-777607 on breast cancer cell growth and apoptotic death.
Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Guangwei Liu,Yujing Bi,Bo Shen,Hui Yang,Yan Zhang,Xiao Wang,Huanrong Liu,Yun Lu,Jiongbo Liao,Xi Chen,Yiwei Chu

DOI: https://doi.org/10.1158/0008-5472.22401441.v1

2023-01-01

Abstract:PDF file - 436K, Fig.S1. MDSC polarizing differentiation condition alters glycolytic activity. Fig.S2.MDSC SIRT1 expansions in spleen and tumor of SIRT1KO and WT-bearing tumor mice. Fig.S3.SIRT1 deficiency MDSCs showed normal cell death and proliferation. Fig.S4.SIRT1 is required for MDSC polarization. Fig.S5.Characterization of surface marker of bone marrow-derived MDSCs. Fig.S6.SIRT1 intrinsicly controls the function and differentiation of tumor MDSCs. Fig.S7.The potentiating killing activity of SIRT1-/- MDSCs is associated with the higher glycolytic activity. Fig.S8.CD115+ monocytic MDSC effects in tumor killing. Fig.S9.SIRT1 deficiency from MDSCs could not alter the activation of NF-κB signaling after LPS treatment. Fig.S10.SIRT1-dependent MDSC glycolytic activity changes are associated with mTOR-HIF1α pathway. Fig.S11.SIRT-HIF axis directs the function and fate of MDSC associated with glycolytic activity. Fig.S12.SIRT-HIF axis potentiates glycolytic activity and tumor killing ability. Fig.S13.SIRT1 masters MDSC function and fate in tumor through mTOR/HIF1α dependent glycolytic pathway.
Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Long-Kuan Ran,Yong Chen,Zhenzhen Zhang,Na-Na Tao,Ji-Hua Ren,Zhou Li,Hua Tang,Xiang Chen,Ke Chen,Wanyu Li,Aiping Huang,Juan Chen

DOI: https://doi.org/10.1158/1078-0432.22455327.v1

2023-01-01

Abstract:SIRT6 depletion increased cell sensitivity to doxorubicin. Cells in different groups with or without doxorubicin treatment were subjected to flow cytometry with Annexin V/PI (A) and to PARP cleavage analysis (B). *, p<0.01.
Supplementary Figure 6 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406508.v1

2023-01-01

Abstract:Efficient knockdown of IRF1 using siRNA.
Figure S12 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602161

2024-01-01

Abstract:Figure S12. Individual tumor growth curves of parental MDA-MB-231 tumor-bearing mice subjected to different treatments (related to Figure 5B).
SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents.

Warren Fiskus,Veena Coothankandaswamy,Jianguang Chen,Hongwei Ma,Kyungsoo Ha,Dyana T. Saenz,Stephanie S. Krieger,Christopher P. Mill,Baohua Sun,Peng Huang,Jeffrey S. Mumm,Ari M. Melnick,Kapil N. Bhalla

DOI: https://doi.org/10.1158/0008-5472.can-16-0126

IF: 11.2

2016-01-01

Cancer Research

Abstract:AbstractSIRT2 is a protein deacetylase with tumor suppressor activity in breast and liver tumors where it is mutated; however, the critical substrates mediating its antitumor activity are not fully defined. Here we demonstrate that SIRT2 binds, deacetylates, and inhibits the peroxidase activity of the antioxidant protein peroxiredoxin (Prdx-1) in breast cancer cells. Ectopic overexpression of SIRT2, but not its catalytically dead mutant, increased intracellular levels of reactive oxygen species (ROS) induced by hydrogen peroxide, which led to increased levels of an overoxidized and multimeric form of Prdx-1 with activity as a molecular chaperone. Elevated levels of SIRT2 sensitized breast cancer cells to intracellular DNA damage and cell death induced by oxidative stress, as associated with increased levels of nuclear FOXO3A and the proapoptotic BIM protein. In addition, elevated levels of SIRT2 sensitized breast cancer cells to arsenic trioxide, an approved therapeutic agent, along with other intracellular ROS-inducing agents. Conversely, antisense RNA-mediated attenuation of SIRT2 reversed ROS-induced toxicity as demonstrated in a zebrafish embryo model system. Collectively, our findings suggest that the tumor suppressor activity of SIRT2 requires its ability to restrict the antioxidant activity of Prdx-1, thereby sensitizing breast cancer cells to ROS-induced DNA damage and cell cytotoxicity. Cancer Res; 76(18); 5467–78. ©2016 AACR.
Resveratrol Induces Apoptosis in Breast Cancer Cells by E2f1-Mediated Up-Regulation of Aspp1

Yujie Shi,Shihe Yang,Sandi Troup,Xin Lu,Steve Callaghan,David S. Park,Ying Xing,Xiaohe Yang

DOI: https://doi.org/10.3892/or.2011.1248

2011-01-01

Oncology Reports

Abstract:Resveratrol is a natural polyphenolic compound with cancer chemopreventive activity. However, our understanding of the molecular mechanism responsible for resveratrol-induced apoptosis is still very limited. Here, we used MCF-7 and MDA-MB231 breast cancer cells as a model to demonstrate that resveratrol induced the expression of ASPP1, a new member of the ASPP (apoptosis stimulation protein of p53) family, which plays an important role in the regulation of apoptosis. Moreover, resveratrol enhanced apoptosis of MCF-7/ASPP1 cells, accompanied by higher expression of bax and p21. In contrast, siRNA-mediated knockdown of ASPP1 inhibited apoptosis in MB231 cells. Furthermore, we found that higher levels of ASPP1 were associated with adenovirus-mediated overexpression of E2F1 while siRNA-mediated E2F1 knockdown led to down-regulation of ASPP1. In conclusion, our results demonstrate that overexpression of ASPP1 rendered MCF-7 and MDA-MB231 breast cancer cells more sensitive to resveratrol-mediated apoptosis via the E2F pathway, thus suggesting that ASPP1 may represent a novel therapeutic target for resveratrol in human breast cancer.
Supplementary Figure 5 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406511.v1

2023-01-01

Abstract:dnIRF1 blocks ICI sensitivity in LCC1 cells.
Supplementary Figures 1 - 5 from IRP2 Regulates Breast Tumor Growth

Wei Wang,Zhiyong Deng,Heather Hatcher,Lance D. Miller,Xiumin Di,Lia Tesfay,Guangchao Sui,Ralph B. D'Agostino,Frank M. Torti,Suzy V. Torti

DOI: https://doi.org/10.1158/0008-5472.22402194

2023-01-01

Abstract:PDF file - 514K, Supplemental Figures 1-5. Supplemental Fig 1: IRP2, TfR1 and Ferritin H transcript levels in a series of breast cancer cell lines examined by real-time qPCR. Supplemental Fig 2. IRP2, TfR1 and Ferritin H transcript levels in IRP2 knockdown MDA-MB-231 cells. Supplemental Fig 3. Growth of MCF7 cells following IRP2 knockdown. Supplemental Fig 4. IRP2 overexpression is not sufficient to increase proliferation of MCF10A cells. Supplemental Fig 5. Bioluminescent images of tumor xenografts on day 32.
Figure S13 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Yan Liu,Jiahui Chen,Jia Tian,Yu Hao,Xinxing Ma,Yehui Zhou,Liangzhu Feng

DOI: https://doi.org/10.1158/2326-6066.27602158

2024-01-01

Abstract:Figure S13. Individual tumor growth curves of brain metastatic MDA-MB-231 tumor-bearing mice subjected to different treatments (related to Figure 5F).
Supplementary Figure 1 from ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth Via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence

Lijun Jia,Maria S. Soengas,Yi Sun

DOI: https://doi.org/10.1158/0008-5472.22378625.v1

2023-01-01

Abstract:Supplementary Figure 1 from ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence
Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

Yan Li,Junye Liu,Xinping Liu,Kefei Xing,Yun Wang,Fuyang Li,Libo Yao

DOI: https://doi.org/10.1385/ABAB:135:3:181

2006-01-01

Applied Biochemistry and Biotechnology

Abstract:Resveratrol ( trans -3,4N,-5-trihydroxystilbene), a phytoalexin present in grapes and red wine, is emerging as a natural compound with potential anticancer properties. Here we show that resveratrol affects the growth of human breast cancer cell lines MCF7, MDA-MB-231, SK-BR-3, and Bcap-37 in a dose-dependent manner and that MCF7 is the most sensitive among the four cell lines. MCF7 cells treated with resveratrol showed typical characteristics of apoptosis including the poly (ADP-ribose) polymerase cleavage, TdT-mediated dUTP nick end labeling-positive staining, and morphologic changes. Phosphorylation of the oncogene product Akt was significantly reduced followed by decreased phosphorylation and increased processing of pro-caspase-9 on resveratrol treatment. These results indicate that resveratrol seems to exert its growth-inhibitory/apoptotic effect on the breast cancer cell line MCF7 via the Akt-caspase-9 pathway.
Supplementary Figure 4 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406514.v1

2023-01-01

Abstract:Knockdown of IRF1 alters BECN1 and IGF1R/mTOR expression.
Supplementary Figure 3 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406517

2023-01-01

Abstract:Silencing ATG7 and BECN1 induces IRF1 expression independently of ROS.
Supplementary Figure 2 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Jessica L. Schwartz-Roberts,Katherine L. Cook,Chun Chen,Ayesha N. Shajahan-Haq,Margaret Axelrod,Anni Wärri,Rebecca B. Riggins,Lu Jin,Bassem R. Haddad,Bhaskar V. Kallakury,William T. Baumann,Robert Clarke

DOI: https://doi.org/10.1158/0008-5472.22406520.v1

2023-01-01

Abstract:Nuclear IRF1 is induced following ATG7 and BECN1 knockdown.

Supplementary Figure 2 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Data from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplementary Figure 5 from SRT1720 Induces Lysosomal-Dependent Cell Death of Breast Cancer Cells

Supplemental Figures 1-5 from SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents

Resveratrol Induces Gastric Cancer Cell Apoptosis Via Reactive Oxygen Species, but Independent of Sirtuin1.

Supplementary Figure 1 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figure 2 from Small-Molecule Inhibitor BMS-777607 Induces Breast Cancer Cell Polyploidy with Increased Resistance to Cytotoxic Chemotherapy Agents

Supplementary Figures 1 - 13 from SIRT1 Limits the Function and Fate of Myeloid-Derived Suppressor Cells in Tumors by Orchestrating HIF-1<b>α</b>–Dependent Glycolysis

Supplementary Figure 2 from SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma Via BCL2-Associated X Protein–Dependent Apoptotic Pathway

Supplementary Figure 6 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Figure S12 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents.

Resveratrol Induces Apoptosis in Breast Cancer Cells by E2f1-Mediated Up-Regulation of Aspp1

Supplementary Figure 5 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figures 1 - 5 from IRP2 Regulates Breast Tumor Growth

Figure S13 from Engineered CAR-NK Cells with Tolerance to H2O2 and Hypoxia Can Suppress Postoperative Relapse of Triple-Negative Breast Cancers

Supplementary Figure 1 from ROC1/RBX1 E3 Ubiquitin Ligase Silencing Suppresses Tumor Cell Growth Via Sequential Induction of G2-M Arrest, Apoptosis, and Senescence

Resveratrol-induced cell inhibition of growth and apoptosis in MCF7 human breast cancer cells are associated with modulation of phosphorylated akt and caspase-9

Supplementary Figure 4 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 3 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate

Supplementary Figure 2 from Interferon Regulatory Factor-1 Signaling Regulates the Switch Between Autophagy and Apoptosis to Determine Breast Cancer Cell Fate